|
Laxman Pai, Opalesque Asia: The global investment firm KKR & Co. has raised $4 billion for its second fund focused on investing in high-growth healthcare companies.
According to a press release from the private equity firm, the Health Care Strategic Growth Fund II (HCSG II) is dedicated to health care growth equity investment opportunities primarily in North America and Europe.
With a diversified portfolio approach, HCSG II will focus on the biopharmaceutical, medical device, health care services, life science tools/diagnostics, and health care information technology sub-sectors, the release added.
HCSG II is the successor fund to KKR Health Care Strategic Growth Fund, KKR's first dedicated health care growth equity vehicle, which held its final closing in November 2017 on US$ 1.45 billion in capital commitments.
HCSG II received strong support from a diverse group of both new and existing investors globally, including public pension plans, sovereign wealth funds, insurance companies, financial institutions, endowments, private wealth and fintech platforms, family offices, and high-net-worth individual investors. KKR will be investing approximately $500 million of capital in the Fund alongside these investors through the Firm's balance sheet, affiliates, and employee commitments.
Alisa Amarosa Wood, Partner and Head of the Private Markets Strategies Group at KKR said: "At nearly three times the size of its predecessor, HCSG II not only speaks to the attract...................... To view our full article Click here
|
RSS
